NCT00141817
Study Evaluating Pantoprazole in Children With GERD
Sponsored by Wyeth is now a wholly owned subsidiary of Pfizer
The purpose of this study is to characterize the PK profile, safety and tolerability of single and multiple doses of pantoprazole in children aged 1 through 11 years with endoscopically proven GERD.
Inclusion Criteria: * Endoscopically proven GERD diagnosed within 6 months before study entry. * Weight must be equal to or over 8.3 kg; for subjects 6 years or greater, weight must be equal to or under 25 kg Exclusion Criteria: * History of GI disorders, ie, unrepaired tracheal esophageal fistula, GI malabsorption, Eosinophilic esophagitis * Subjects 6-11 years old unable to swallow tablets
Little Rock, Arkansas, United States
Orange, California, United States
San Diego, California, United States
Washington D.C., District of Columbia, United States
Gainesville, Florida, United States
Miami, Florida, United States
Pensacola, Florida, United States
Park Ridge, Illinois, United States
Indianapolis, Indiana, United States
Louisville, Kentucky, United States
Boston, Massachusetts, United States
Boston, Massachusetts, United States
Brockton, Massachusetts, United States
Detroit, Michigan, United States
Flint, Michigan, United States
Jackson, Mississippi, United States
Kansas City, Missouri, United States
New York, New York, United States
Cincinnati, Ohio, United States
Memphis, Tennessee, United States
Temple, Texas, United States
Salt Lake City, Utah, United States
Milwaukee, Wisconsin, United States
Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.
Interested in this trial?
Express your interest and we'll connect you with the trial team.
Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.
Conditions